Page results
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
The Patient Advice and Liaison Service (PALS) provides impartial advice and assistance in answering questions and resolving concerns that patients, their relatives, friends and carers might have accessing the NHS services provided by UCLH.
-
A research study has found that patients who get their chest X-ray results immediately are diagnosed in half the usual time.
-
Omnipod 5 users will get a notification on their Omnipod 5 Controller to install a software update (version 2.0).
-
Jean Degala tells us how the right support, teamwork, effective communication, determination and dedication have helped her grow into the role.
-
Read more about the award for researcher behind first treatment for rare disease
-
The Freedom of Information Act 2000 (FOIA) came into force on 1 January 2005 giving members of the public certain rights to ask public authorities for information relating to the public authority.
File results
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0288 - Cancer treatment capacity
-
FOI/2023/0280 - Psychiatric inpatient wards - parental and family
-
FOI/2023/0281 - Bariatric equipment
-
FOI/2023/0284 - IT services management platform/ user licences
-
FOI/2023/0286 - Maternity services budget for 2018/19-2022/23
-
FOI/2023/0294 - Patient entertainment
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0290 - Specialist palliative care units within the Trust